Search results
Results from the WOW.Com Content Network
J&JPRD was created in 2001 through the merging of various research organizations including McNeil Pharmaceuticals, Janssen Research Foundation, Three Dimensional Pharmaceuticals, and the R. W. Johnson Pharmaceutical Research Institute.
2 Pharmaceutical therapies. 3 References. ... In medical technologies, J&J's major franchises include interventional solutions, orthopedics, surgery, and vision. [1]
Eleusis is a pharmaceutical company that is developing serotonin 5-HT 2A receptor agonists related to serotonergic psychedelics as novel anti-inflammatory drugs to treat inflammatory diseases. [ 1 ] [ 4 ] It is interested in developing the drugs for treatment of conditions like asthma , cardiovascular disease , and Crohn's disease , but is ...
For 129 years, New Brunswick has served as the headquarters of J&J, America’s seventh most valuable public company. With consumer products from Band-Aids to baby powder, Neutrogena to Rogaine, Listerine to Visine, Aveeno to Tylenol and Sudafed to Splenda, Johnson & Johnson is the biggest and, according to multiple surveys , most admired ...
Janssen Pharmaceuticals was the first Western pharmaceutical company to set up a pharmaceutical factory in the People's Republic of China. [27] In 1976, Paul Janssen met Ma Haide (born George Shafik Hatem), a Lebanese-American doctor who had started working in China in 1933. After three days of meetings, the two agreed to bring a modernized ...
As Americans are increasingly reaching for pharmaceutical solutions for depression—about one in eight U.S. adults takes antidepressants—scientists have been innovating novel treatments for it.
Johnson & Johnson (J&J) is an American multinational pharmaceutical, biotechnology, and medical technologies corporation headquartered in New Brunswick, New Jersey, and publicly traded on the New York Stock Exchange.
These pharmaceutical companies were pioneers and leaders in areas such as pain management, acid reflux disease, and infectious diseases. [ 2 ] Ortho-McNeil and Janssen Pharmaceuticals together composed the Ortho-McNeil-Janssen group within Johnson & Johnson before a decision to operate under the Janssen Pharmaceuticals name in 2011.